NG tube insertion - Nursing Case Study
Pathophysiology
• Primary mechanism: Nasogastric (NG) tube insertion facilitates gastric decompression by providing a direct conduit for removing gastric contents, thereby alleviating pressure and preventing aspiration in patients with gastrointestinal obstructions or impaired gastric motility.
• Secondary mechanism: The NG tube allows for the administration of nutrients and medications directly into the stomach, bypassing oral intake, which is crucial for patients with swallowing difficulties or those who require bowel rest.
• Key complication: Incorrect placement or prolonged use of the NG tube can lead to nasal and esophageal irritation, potential tissue damage, or inadvertent entry into the respiratory tract, underscoring the need for proper placement verification and monitoring.
Patient Profile
Demographics:
56-year-old female, retired teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Gastroesophageal Reflux Disease (GERD)
• Current medications: Lisinopril, Metformin, Omeprazole
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Abdominal discomfort and difficulty with NG tube feeding
• Key symptoms: Bloating, nausea, mild abdominal pain, occasional coughing
• Vital signs: Temperature: 99.1°F, Heart Rate: 98 bpm, Blood Pressure: 145/90 mmHg, Respiratory Rate: 20 breaths per minute, Oxygen Saturation: 95% on room air
Section 1
As the nursing team continues to monitor the 56-year-old patient with an NG tube, they observe a change in her status that warrants further investigation. The patient begins to exhibit increased respiratory distress, characterized by a respiratory rate of 24 breaths per minute and a slight drop in oxygen saturation to 92% on room air. She complains of worsening abdominal pain, now rated at 6/10 on the pain scale, and has developed a persistent cough. Auscultation reveals diminished breath sounds in the right lower lung field, raising concerns for possible aspiration or other respiratory complications.
In response to these findings, the clinical team decides to perform a chest X-ray to evaluate the position of the NG tube and assess for any signs of aspiration pneumonia. The results indicate that the tip of the NG tube appears to be in the right main bronchus, rather than the stomach, suggesting inadvertent placement into the respiratory tract. Additionally, there are patchy infiltrates in the right lower lobe, consistent with aspiration. Laboratory tests reveal a mild leukocytosis, with a white blood cell count of 12,500/mm³, further supporting the suspicion of an infectious process.
Given these developments, the team promptly removes the NG tube and initiates appropriate interventions. The patient is placed on supplemental oxygen to maintain adequate saturation levels, and broad-spectrum antibiotics are started to address the suspected pneumonia. The clinical team discusses the importance of reassessing the need for an NG tube and considers alternative methods for gastric decompression and nutritional support. This situation highlights the critical need for vigilant monitoring of NG tube placement and the potential complications that can arise, requiring timely and effective clinical reasoning to ensure patient safety and recovery.
Section 2
As the clinical team continues to monitor the patient following the removal of the NG tube and the initiation of antibiotics, they observe a gradual improvement in her respiratory status. Her respiratory rate decreases to 20 breaths per minute with oxygen saturation improving to 95% on 2 liters of oxygen via nasal cannula. However, despite the positive changes in her respiratory parameters, the patient reports persistent abdominal discomfort, now rated at 5/10. Physical examination reveals mild abdominal distension and hypoactive bowel sounds, suggesting ongoing gastrointestinal concerns.
To further evaluate the patient's abdominal symptoms, the team orders an abdominal ultrasound. The results indicate mild gastric distension with free fluid suggestive of possible ascites, but no overt signs of bowel obstruction. These findings necessitate a reassessment of the patient's fluid status and nutritional needs. The team decides to initiate parenteral nutrition to ensure adequate caloric intake while minimizing the risk of further aspiration. Additionally, a nasojejunal tube is considered for future enteral feeding, given its lower risk of aspiration compared to an NG tube.
The patient's laboratory results show a slight increase in her liver enzymes and a mild electrolyte imbalance, with a potassium level of 3.3 mmol/L and a sodium level of 130 mmol/L. These findings prompt the team to adjust her electrolyte replacement regimen and closely monitor her liver function. This scenario underscores the importance of comprehensive management in patients with complex medical needs, highlighting the need for ongoing assessment and timely interventions to address new complications as they arise.
Section 3
As the clinical team continues to monitor the patient's response to parenteral nutrition and electrolyte replacement, they note a series of changes in her clinical status. Over the next 24 hours, the patient reports a decrease in abdominal pain, now rated at 3/10, and a slight reduction in abdominal distension. However, her physical examination reveals a new finding: the presence of mild jaundice, particularly noticeable in the sclera. Vital signs remain stable, with a temperature of 98.7°F, a heart rate of 78 beats per minute, and blood pressure of 118/76 mmHg, but there is concern regarding her liver function.
A repeat set of laboratory tests is conducted to assess the patient's liver function and electrolyte status. The results show a further elevation in liver enzymes, with an AST level increasing to 95 U/L and ALT to 105 U/L. Bilirubin levels are also elevated, with a total bilirubin of 2.5 mg/dL. Meanwhile, the electrolyte imbalance persists, with potassium improving slightly to 3.5 mmol/L but sodium remaining low at 129 mmol/L. These findings suggest worsening hepatic function, potentially linked to the underlying gastrointestinal issues or a reaction to medications.
In light of these developments, the healthcare team initiates a more comprehensive evaluation of the patient's liver status, considering potential hepatobiliary causes for the jaundice and enzyme elevation. An abdominal MRI is scheduled to provide a clearer picture of the liver and surrounding structures. Additionally, the team reviews the patient's medication regimen to identify any hepatotoxic agents and adjusts accordingly. This evolving scenario requires careful clinical reasoning to balance the patient's nutritional needs, manage her electrolyte and liver function, and prevent further complications, setting the stage for the next phase of her treatment plan.
Section 4
As the healthcare team refines their approach to managing the patient's condition, the abdominal MRI reveals mild intrahepatic cholestasis, which may explain the jaundice and elevated liver enzymes. This finding suggests that the patient's hepatic complications are not solely attributable to medication but may be linked to a secondary biliary obstruction or a metabolic liver dysfunction. The MRI also indicates mild hepatic steatosis, which could be contributing to the liver’s impaired ability to process and excrete bilirubin. These findings prompt the team to consider additional causes, such as a potential underlying metabolic disorder or the effects of malnutrition on liver function.
In response to the MRI results, the clinical team decides to adjust the patient's nutritional plan, ensuring that it is tailored to support liver health while continuing to address her gastrointestinal needs. They consult with a dietitian to integrate a hepatic-friendly, nutrient-rich formula that minimizes hepatic stress and optimizes protein and calorie intake. Concurrently, the team reassesses the patient's medication list, discontinuing any non-essential drugs that may exacerbate liver issues, and opts for agents with lower hepatotoxic potential.
Monitoring continues with a focus on both liver function tests and electrolyte balance, as the team anticipates gradual improvement with these targeted interventions. The patient's vital signs remain stable, but the team is vigilant in observing for any signs of deteriorating liver function or new complications. This careful balance of clinical decision-making and patient-centered care is crucial as they navigate the complexities of her condition, paving the way for further adjustments and setting the stage for ongoing evaluation and treatment.
Section 5
As the healthcare team continues to monitor the patient, they observe a change in her status that prompts further investigation. Over the past 48 hours, the patient has developed mild abdominal distension and discomfort, accompanied by a slight increase in her bilirubin levels, now at 3.2 mg/dL, and liver enzymes that remain elevated with AST at 85 U/L and ALT at 90 U/L. Her vital signs are generally stable, with a temperature of 98.6°F, heart rate of 78 bpm, blood pressure of 120/75 mmHg, and respiratory rate of 18 breaths per minute. However, the abdominal examination reveals hypoactive bowel sounds, and the patient reports a sensation of fullness and decreased appetite.
Given these new symptoms, the clinical team decides to perform an abdominal ultrasound to assess for potential complications related to the recent NG tube insertion and to rule out any obstruction or other mechanical issues. The ultrasound reveals mild ascites and a slightly dilated common bile duct, raising concerns about a possible biliary obstruction that may be contributing to the patient's symptoms and liver function abnormalities. These findings suggest that the intrahepatic cholestasis may be exacerbated by an external factor, possibly linked to the patient's nutritional status and the recent changes in her diet and medication regimen.
In response to these new diagnostic results, the healthcare team considers adjusting the patient's management plan. They prioritize addressing the potential biliary obstruction, exploring whether an endoscopic retrograde cholangiopancreatography (ERCP) might be indicated to further investigate and potentially relieve any obstruction. Additionally, the team closely reviews the patient's nutritional intake and fluid management, ensuring that she receives adequate hydration and electrolyte support while minimizing any possible contributors to her hepatic stress. This comprehensive approach aims to stabilize the patient's condition and prevent further complications, facilitating her gradual recovery and continued evaluation of underlying metabolic or nutritional factors that may be impacting her liver function.